Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma treated with cabozantinib and nivolumab

por Salazar Mejía, Carlos Eduardo, Oyervides Juárez, Víctor Manuel, Wimer Castillo, Blanca Otilia, Vidal Gutiérrez, Oscar, Garza Guajardo, Raquel, Grande, Enrique
Publicado 2020

696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial

por Choueiri, T.K., Powles, T., Burotto, M., Bourlon, M.T., Zurawski, B., Oyervides Juárez, Víctor Manuel, Hsieh, J.J., Basso, U., Shah, A.Y., Suarez, C., Hamzaj, A., Barrios, C.H., Richardet, M., Pook, D., Tomita, Y., Escudier, B., Zhang, J., Simsek, B., Apolo, A.B., Motzer, R.J.
Publicado 2020